Announced Actions for April 18, 2003

Release of Commission report: The Commission has authorized staff to publicly release a report entitled "Federal Trade Commission Performance Report for Fiscal Year 2002." The Fiscal Year 2002 Report is the fourth performance report required under the Government Performance and Results Act of 1993 (GPRA). The Report supplements the Commission's five-year Strategic Plan for fiscal years 2000-2005, which was approved in September 2000. The agency's Performance Plans implement the Commission's strategic goals by establishing annual performance targets. The Performance Report compares and evaluates each year's actual performance to the established targets set forth in the Performance Plan. The Commission vote to release the report was 5-0. (FTC File No. P010101; staff contact is Henry Hoffman, FTC Chief Financial Officer, 202-326-2664.)

Commission approval of final consent order: Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning Bristol-Myers Squibb. The Commission vote to approve the final consent order was 5-0. (FTC File Nos. 001-0221, Taxol; 011-0046, Buspar; and 021-0181, Cisplatin; staff contact is Jeffrey Brennan, Assistant Director, Bureau of Competition, 202-326-3688; see press release dated March 7, 2003.)

Copies of the documents mentioned in this release are available from the FTC's Web site at http://www.ftc.gov and also from the FTC's Consumer Response Center, Room 130, 600 Pennsylvania Avenue, N.W., Washington, D.C. 20580. Call toll-free: 1-877-FTC-HELP.